drugset / Trial / NCT06153706

Evaluation of L-PRF as an Antibiotic Slow-release Biological Device in the Treatment of Moderate Periodontitis

NCT06153706

Phase 2/3 Completed 24 enrolled Yasmeen Khaled
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aimed to evaluate the efficacy of leukocyte platelet-rich fibrin (L-PRF) as a local sustained released device for antibiotics.

Timeline

Start
2022-06-01
Primary completion
2023-10-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule Other

Indications